In addition, previous studies have indicated that PRR11 overexpression promotes ovarian cancer cell proliferation, migration and invasion by activating the PI3K/AKT/β-Catenin pathway (13) and promoting breast cancer cell progression and invasion by activating the epithelial-mesenchymal transition (EMT) process (10). Here, PRR11 is linked to ovarian cancer.